体外膜肺氧合相关中枢神经系统并发症及防治策略

doi:10.3969/j.issn.1006-7795.2021.06.009

摘要/Abstract

摘要： 体外膜肺氧合(extra corporeal membrane oxygenation, ECMO)是危重患者生命支持的重要救治技术,同时也伴随有许多并发症,其中ECMO相关中枢神经系统并发症是导致患者严重不良转归的重要危险因素之一。目前ECMO相关中枢神经系统并发症的真实患病率尚不清楚,据报道其发生率约13%～27%,主要表现为以下五种类型:缺血性卒中、脑出血、癫痫、全脑缺血-缺血缺氧性脑病、脑死亡。ECMO合并中枢神经系统并发症包含多种危险因素,治疗主要依靠内科手段。近些年的研究热点集中在脑电监测(electroencephalography, EEG)等无创监测方面。合并中枢神经系统并发症患者的病死率较未发生者明显升高。通过神经功能监测,可早期发现神经功能损伤进而早期干预并可能改善患者预后。

关键词: 体外膜肺氧合, 神经系统并发症, 流行病学, 神经功能监测

Abstract: Extra corporeal membrane oxygenation(ECMO) is an extracorporeal life support for life-threatening cardiopulmonary failure. Although many patients survive due to its introduction, significant neurological complications like seizures, ischemic strokes, intracranial hemorrhage, ischemic hypoxic encephalopathy, and brain death occur during ECMO and lead to serious adverse outcomes, with high frequency and associated mortality of neurological complications. Although the incidence is reported ranging from 13% to 27%, the prevalence of ECMO-related neurological complications is still unclear. Neurological complications in patients during ECMO associated with lots of risk factors, while the treatments mainly depend on internal medicine. In recent years, non-invasive monitoring is brought into focus, such as electroencephalography (EEG) monitoring and so on.The mortality of patients with ECMO-related neurological complications is much higher than those patients without.The systematic neurological monitoring and early intervention may improve the outcomes.

Key words: extra corporeal membrane oxygenation(ECMO), neurological complications, epidemiology, neurofunction monitoring

中图分类号:

R459

苗明月, 张琳琳, 周建新. 体外膜肺氧合相关中枢神经系统并发症及防治策略[J]. 首都医科大学学报, 2021, 42(6): 956-960.

Miao Mingyue, Zhang Linlin, Zhou Jianxin. Recognition and management of neurological complications during extra corporeal membrane oxygenation[J]. Journal of Capital Medical University, 2021, 42(6): 956-960.

参考文献

[1] Makdisi G, Wang I W. Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology[J]. J Thorac Dis, 2015, 7(7): E166-E176.
[2] McCarthy F H, Mcdermott K M, Kini V, et al. Trends in U.S. extracorporeal membrane oxygenation use and outcomes: 2002-2012[J]. Semin Thoracic Cardiovasc Surg, 2015, 27(2): 81-88.
[3] Cho H W, Song I A, Oh T K. Trends in extracorporeal membrane oxygenation treatment from 2005 to 2018 in South Korea[J]. Perfusion, 2021, 20: 2676591211018130.
[4] Thiagarajan R R, Barbaro R P, Rycus P T, et al. Extracorporeal life support organization registry international report 2016[J]. ASAIO J, 2017, 63(1): 60-67.
[5] Savarimuthu S, Binsaeid J, Harky A. The role of ECMO in COVID-19: can it provide rescue therapy in those who are critically ill?[J]. J Card Surg, 2020, 35(6): 1298-1301.
[6] Sutter R, Tisljar K, Marsch S. Acute neurologic complications during extracorporeal membrane oxygenation[J]. Crit Care Med, 2018, 46(9): 1506-1513.
[7] Migdady I, Rice C, Deshpande A, et al. Brain injury and neurologic outcome in patients undergoing extracorporeal cardiopulmonary resuscitation[J]. Criti Care Med, 2020, 48(7): e611-e619.
[8] Shoskes A, Migdady I, Rice C, et al. Brain injury is more common in venoarterial extracorporeal membrane oxygenation than venovenous extracorporeal membrane oxygenation: a systematic review and meta-analysis[J]. Crit Care Med, 2020, 48(12): 1799-1808.
[9] Cho S M, Farrokh S, Whitman G, et al. Neurocritical care for extracorporeal membrane oxygenation patients[J]. Crit Care Med, 2019, 47(12): 1773-1781.
[10] Cho S M, Geocadin R G, Caturegli G, et al. Understanding characteristics of acute brain injury in adult extracorporeal membrane oxygenation: an autopsy study[J]. Crit Care Med, 2020, 48(6): e532-e536.
[11] Lorusso R, Barili F, Mauro M D, et al. In-hospital neurologic complications in adult patients undergoing venoarterial extracorporeal membrane oxygenation[J]. Crit Care Med, 2016, 44(10): e964-e972.
[12] Honore P M, Barreto Gutierrez L, Kugener L, et al. Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?[J]. Crit Care, 2020, 24(1): 450.
[13] Luyt C E, Bréchot N, Demondion P, et al. Brain injury during venovenous extracorporeal membrane oxygenation[J]. Intensive Care Med, 2016, 42(5): 897-907.
[14] Cho S M, Ritzl E K. Neurological prognostication using electroencephalogram in adult veno-arterial extracorporeal membrane oxygenation: limitations and recommendations[J]. Neurocrit Care, 2020, 33(3): 652-654.
[15] Bembea M M, Felling R, Anton B, et al. Neuromonitoring during extracorporeal membrane oxygenation[J]. Pediatr Crit Care Med, 2015, 16(6): 558-564.
[16] Devlin J W, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU[J]. Crit Care Med, 2018, 46(9): e825-e873.
[17] Cho S M, Ziai W, Mayasi Y, et al. Noninvasive neurological monitoring in extracorporeal membrane oxygenation[J]. ASAIO J, 2020, 66(4): 388-393.
[18] Magalhaes E R B, Reuter J C, Wanono R, et al. Early EEG for prognostication under venoarterial extracorporeal membrane oxygenation[J]. Neurocrit Care, 2020, 33(3): 688-694.
[19] Westhall E, Rossetti A O, van Rootselaar A F, et al. Standardized EEG interpretation accurately predicts prognosis after cardiac arrest[J]. Neurology, 2016, 86(16): 1482-1490.
[20] Cho S M, Geocadin R G, White B, et al. Neuropathological findings in comatose patients with venoarterial extracorporeal membrane oxygenation[J]. Int Artif Organs, 2020, 43(9): 614-619.
[21] Hunt M F, Clark K T, Whitman G, et al. The use of cerebral nirs monitoring to identify acute brain injury in patients with VA-ECMO[J]. J Intensive Care Med, 2020, 15:885066620966962.
[22] Kavi T, Esch M, Rinsky B, et al. Transcranial doppler changes in patients treated with extracorporeal membrane oxygenation[J]. J Stroke Cerebrovasc Dis, 2016, 25(12): 2882-2885.
[23] Melmed K R, Schlick K H, Rinsky B, et al. Assessing cerebrovascular hemodynamics using transcranial doppler in patients with mechanical circulatory support devices[J]. J Neuroimaging, 2020, 30(3): 297-302.
[24] O′ Brien N F, Buttram S D W, Maa T, et al. Cerebrovascular physiology during pediatric extracorporeal membrane oxygenation[J]. Pediatr Criti Care Med, 2019, 20(2): 178-186.
[25] Grinspan Z M, Pon S, Greenfield J P, et al. multimodal monitoring in the pediatric intensive care unit: new modalities and informatics challenges[J]. Semin Pediatr Neuro, 2014, 21(4): 291-298.
[26] Khan I, Rehan M, Parikh G, et al. Regional cerebral oximetry as an indicator of acute brain injury in adults undergoing veno-arterial extracorporeal membrane oxygenation-A Prospective Pilot Study[J]. Front Neurol, 2018, 9:993.
[27] Pozzebon S, Blandino Ortiz A, Franchi F, et al. Cerebral near-infrared spectroscopy in adult patients undergoing veno-arterial extracorporeal membrane oxygenation[J]. Neurocrit Care, 2018, 29(1): 94-104.
[28] Tsou P Y, Garcia A V, Yiu A, et al. Association of cerebral oximetry with outcomes after extracorporeal membrane oxygenation[J]. Neurocrit Care, 2020, 33(2): 429-437.
[29] Floerchinger B, Philipp A, Foltan M, et al. Neuron-specific enolase serum levels predict severeneuronal injury after extracorporeal life support in resuscitation[J]. Eur J Cardiothoracic Surgery, 2014, 45(3): 496-501.
[30] Nguyen D N, Huyghens L, Wellens F, et al. Serum S100B protein could help to detect cerebral complications associated with extracorporeal membrane oxygenation (ECMO)[J]. Neurocrit Care, 2014, 20(3): 367-374.
[31] Bembea M M, Rizkalla N, Freedy J, et al. Plasma biomarkers of brain injury as diagnostic tools and outcome predictors after extracorporeal membrane oxygenation[J]. Crit Care Med, 2015, 43(10): 2202-2211.
[32] Cho S M, Canner J, Chiarini G, et al. Modifiable risk factors and mortality from ischemic and hemorrhagic strokes in patients receiving venoarterial extracorporeal membrane oxygenation: results from the extracorporeal life support organization registry[J]. Criti Care Med, 2020, 48(10): e897-e905.
[33] Patel M, Altshuler D, Lewis T C, et al. Sedation requirements in patients on venovenous or venoarterial extracorporeal membrane oxygenation[J]. Ann Pharmacother, 2020, 54(2): 122-130.
[34] Marhong J D, Debacker J, Viau-Lapointe J, et al. Sedation and mobilization during venovenous extracorporeal membrane oxygenation for acute respiratory failure[J]. Criti Care Med, 2017, 45(11): 1893-1899.